Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer

被引:27
作者
Minard, Charles G.
Spitz, Margaret R.
Wu, Xifeng
Hong, Waun Ki
Etzel, Carol J.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Epidemiol, Unit 1340, Houston, TX 77030 USA
[2] Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, Dept Biostat, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
关键词
alcohol consumption; bleomycin-induced chromatid breaks per cell; glutathione S-transferase; mutagen sensitivity; second primary tumors; survival tree analysis; tobacco use;
D O I
10.1002/cncr.21928
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND. The objective of this study was to evaluate the effects of polymorphisms in 2 genes in the glutathione S-transferase (GST) family and the mutagen-sensitivity phenotype on the risk of second primary tumors (SPTs) in patients with previously diagnosed early-stage head and neck squamous cell carcinoma. Data were available for 303 patients who were enrolled in a placebo-controlled chemo-prevention trial of low-dose 13-cis-retinoic acid to reduce the occurrence of SPTs. METHODS. A Cox proportional hazards model and survival tree analysis were used to evaluate the association between specified genetic variations and the development of SPTs. The average number of bleomycin-induced chromatid breaks per cell was used to quantify mutagen sensitivity as an individual patient's degree of sensitivity to genotoxicity. RESULTS. The GST-M1 null genotype was associated with an increased risk for any SPTs (hazard ratio [HR], 1.99; 95% confidence interval [95% CI], 1.11-3.56) and for tobacco-related SPTs (HR, 2.16; 95% CI, 1.01-4.62) after adjusting for covariates. The GST-T1 null genotype and bleomycin-induced chromatid breaks were not associated with a statistically significant increased risk for SPTs or tobacco-related SPTs after similar adjustment. Simultaneous nonnull status for both GST genotypes was associated with a decreased risk for any SPTs (HR, 0.52; 95% CI, 0.28-0.96) and tobacco-related SPTs (HR, 0.50; 95% CI, 0.22-1.11) compared with null status for GST-M1 accompanied by nonnull status for GST-T1. CONCLUSIONS. An association was observed between the development of SPTs and the GST-M1 null genotype after successful treatment for early-stage head and neck squamous cell carcinoma. The GST-T1 null genotype and bleomycin-induced chromatid breaks were not associated with an increased risk, and no significant interactions were identified.
引用
收藏
页码:2636 / 2644
页数:9
相关论文
共 67 条
[11]   2ND CANCERS FOLLOWING ORAL AND PHARYNGEAL CANCERS - ROLE OF TOBACCO AND ALCOHOL [J].
DAY, GL ;
BLOT, WJ ;
SHORE, RE ;
MCLAUGHLIN, JK ;
AUSTIN, DF ;
GREENBERG, RS ;
LIFF, JM ;
PRESTONMARTIN, S ;
SARKAR, S ;
SCHOENBERG, JB ;
FRAUMENI, JF .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (02) :131-137
[12]   Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies [J].
Do, KA ;
Johnson, MM ;
Lee, JJ ;
Wu, XF ;
Dong, Q ;
Hong, WK ;
Khuri, FR ;
Spitz, MR .
CANCER, 2004, 101 (12) :2837-2842
[13]   Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States) [J].
Do, KA ;
Johnson, MM ;
Doherty, DA ;
Lee, JJ ;
Wu, XF ;
Dong, Q ;
Hong, WK ;
Khuri, FR ;
Fu, KK ;
Spitz, MR .
CANCER CAUSES & CONTROL, 2003, 14 (02) :131-138
[14]   Genomic instability in head and neck cancer patients [J].
Friedlander, PL .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (08) :683-691
[15]   Three measures of mutagen sensitivity in a cancer-free population [J].
Gu, J ;
Bondy, ML ;
Sigurdson, A ;
Spitz, MR ;
Hsu, TC ;
Wu, XF .
CANCER GENETICS AND CYTOGENETICS, 1999, 110 (01) :65-69
[16]   Radiotherapy for oral cancer as a risk factor for second primary cancers [J].
Hashibe, M ;
Ritz, B ;
Le, AD ;
Li, G ;
Sankaranarayanan, R ;
Zhang, ZF .
CANCER LETTERS, 2005, 220 (02) :185-195
[17]  
Hashibe M, 2003, CANCER EPIDEM BIOMAR, V12, P1509
[18]   The glutathione S-Transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance [J].
Hayes, JD ;
Pulford, DJ .
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1995, 30 (06) :445-600
[19]  
Hengstler JG, 1998, RECENT RES CANCER, V154, P47
[20]  
Hittelman WN, 2001, ANN NY ACAD SCI, V952, P1